Erik A. Wist

  • Professor emeritus
  • +47-23 01 59 59

Publications 2022

Lofterød T, Frydenberg H, Veierød MB, Jenum AK, Reitan JB, Wist EA, Thune I (2022)
The influence of metabolic factors and ethnicity on breast cancer risk, treatment and survival: The Oslo ethnic breast cancer study
Acta Oncol, 61 (5), 649-657
DOI 10.1080/0284186X.2022.2053573, PubMed 35348396

Lundeby T, Finset A, Kaasa S, Wester TE, Hjermstad MJ, Dajani O, Wist E, Aass N (2022)
A complex communication skills training program for physicians providing advanced cancer care - content development and barriers and solutions for implementation
J Commun Healthc, 16 (1), 46-57
DOI 10.1080/17538068.2022.2039468, PubMed 36919800

Publications 2020

von der Lippe Gythfeldt H, Lien T, Tekpli X, Silwal-Pandit L, Borgen E, Garred Ø, Skjerven H, Schlichting E, Lundgren S, Wist E, Naume B, Kristensen V, Børresen-Dale AL, Lingjaerde OC, Engebraaten O (2020)
Immune phenotype of tumor microenvironment predicts response to bevacizumab in neoadjuvant treatment of ER-positive breast cancer
Int J Cancer, 147 (9), 2515-2525
DOI 10.1002/ijc.33108, PubMed 32488909

Publications 2019

Wist E (2019)
Tidsskr. Nor. Laegeforen., 139 (9), 861

Publications 2018

Höglander EK, Nord S, Wedge DC, Lingjærde OC, Silwal-Pandit L, Gythfeldt HV, Vollan HKM, Fleischer T, Krohn M, Schlitchting E, Borgen E, Garred Ø, Holmen MM, Wist E, Naume B, Van Loo P, Børresen-Dale AL, Engebraaten O, Kristensen V (2018)
Time series analysis of neoadjuvant chemotherapy and bevacizumab-treated breast carcinomas reveals a systemic shift in genomic aberrations
Genome Med, 10 (1), 92
DOI 10.1186/s13073-018-0601-y, PubMed 30497530

Lofterød T, Mortensen ES, Nalwoga H, Wilsgaard T, Frydenberg H, Risberg T, Eggen AE, McTiernan A, Aziz S, Wist EA, Stensvold A, Reitan JB, Akslen LA, Thune I (2018)
Impact of pre-diagnostic triglycerides and HDL-cholesterol on breast cancer recurrence and survival by breast cancer subtypes
BMC Cancer, 18 (1), 654
DOI 10.1186/s12885-018-4568-2, PubMed 29902993

Madssen TS, Thune I, Flote VG, Lundgren S, Bertheussen GF, Frydenberg H, Wist E, Schlichting E, Schäfer H, Fjøsne HE, Vettukattil R, Lømo J, Bathen TF, Giskeødegård GF (2018)
Metabolite and lipoprotein responses and prediction of weight gain during breast cancer treatment
Br J Cancer, 119 (9), 1144-1154
DOI 10.1038/s41416-018-0211-x, PubMed 30401977

Publications 2017

Kvåle R, Myklebust TÅ, Engholm G, Heinävaara S, Wist E, Møller B (2017)
Prostate and breast cancer in four Nordic countries: A comparison of incidence and mortality trends across countries and age groups 1975-2013
Int J Cancer, 141 (11), 2228-2242
DOI 10.1002/ijc.30924, PubMed 28795403

Ohnstad HO, Borgen E, Falk RS, Lien TG, Aaserud M, Sveli MAT, Kyte JA, Kristensen VN, Geitvik GA, Schlichting E, Wist EA, Sørlie T, Russnes HG, Naume B (2017)
Prognostic value of PAM50 and risk of recurrence score in patients with early-stage breast cancer with long-term follow-up
Breast Cancer Res, 19 (1), 120
DOI 10.1186/s13058-017-0911-9, PubMed 29137653

Silwal-Pandit L, Nord S, von der Lippe Gythfeldt H, Møller EK, Fleischer T, Rødland E, Krohn M, Borgen E, Garred Ø, Olsen T, Vu P, Skjerven H, Fangberget A, Holmen MM, Schlitchting E, Wille E, Nordberg Stokke M, Moen Vollan HK, Kristensen V, Langerød A, Lundgren S, Wist E, Naume B, Lingjærde OC, Børresen-Dale AL et al. (2017)
The Longitudinal Transcriptional Response to Neoadjuvant Chemotherapy with and without Bevacizumab in Breast Cancer
Clin Cancer Res, 23 (16), 4662-4670
DOI 10.1158/1078-0432.CCR-17-0160, PubMed 28487444

Sonke GS, Hart LL, Campone M, Erdkamp F, Janni W, Verma S, Villanueva C, Jakobsen E, Alba E, Wist E, Favret AM, Bachelot T, Hegg R, Wheatley-Price P, Souami F, Sutradhar S, Miller M, Germa C, Burris HA (2017)
Ribociclib with letrozole vs letrozole alone in elderly patients with hormone receptor-positive, HER2-negative breast cancer in the randomized MONALEESA-2 trial
Breast Cancer Res Treat, 167 (3), 659-669
DOI 10.1007/s10549-017-4523-y, PubMed 29058175

Vaysse C, Lomo J, Garred O, Fjeldheim F, Lofteroed T, Schlichting E, McTiernan A, Frydenberg H, Husoy A, Lundgren S, Fagerland MW, Richardsen E, Wist EA, Muller C, Thune I (2017)
Inflammation of mammary adipose tissue occurs in overweight and obese patients exhibiting early-stage breast cancer (vol 3, 35, 2017)
npj Breast Cancer, 3, 35
DOI 10.1038/s41523-017-0030-x

Vaysse C, Lømo J, Garred Ø, Fjeldheim F, Lofteroed T, Schlichting E, McTiernan A, Frydenberg H, Husøy A, Lundgren S, Fagerland MW, Richardsen E, Wist EA, Muller C, Thune I (2017)
Inflammation of mammary adipose tissue occurs in overweight and obese patients exhibiting early-stage breast cancer
NPJ Breast Cancer, 3, 19
DOI 10.1038/s41523-017-0015-9, PubMed 28649659

Vaysse C, Lømo J, Garred Ø, Fjeldheim F, Lofteroed T, Schlichting E, McTiernan A, Frydenberg H, Husøy A, Lundgren S, Fagerland MW, Richardsen E, Wist EA, Muller C, Thune I (2017)
Erratum: Inflammation of mammary adipose tissue occurs in overweight and obese patients exhibiting early-stage breast cancer
NPJ Breast Cancer, 3, 35
DOI 10.1038/s41523-017-0030-x, PubMed 28884144

Publications 2016

Dahl AA, Østby-Deglum M, Oldenburg J, Bremnes R, Dahl O, Klepp O, Wist E, Fosså SD (2016)
Aspects of posttraumatic stress disorder in long-term testicular cancer survivors: cross-sectional and longitudinal findings
J Cancer Surviv, 10 (5), 842-9
DOI 10.1007/s11764-016-0529-4, PubMed 26920871

Fjeldheim FN, Frydenberg H, Flote VG, McTiernan A, Furberg AS, Ellison PT, Barrett ES, Wilsgaard T, Jasienska G, Ursin G, Wist EA, Thune I (2016)
Polymorphisms in the estrogen receptor alpha gene (ESR1), daily cycling estrogen and mammographic density phenotypes
BMC Cancer, 16 (1), 776
DOI 10.1186/s12885-016-2804-1, PubMed 27717337

Flote VG, Vettukattil R, Bathen TF, Egeland T, McTiernan A, Frydenberg H, Husøy A, Finstad SE, Lømo J, Garred Ø, Schlichting E, Wist EA, Thune I (2016)
Lipoprotein subfractions by nuclear magnetic resonance are associated with tumor characteristics in breast cancer
Lipids Health Dis, 15, 56
DOI 10.1186/s12944-016-0225-4, PubMed 26970778

Frydenberg H, Thune I, Lofterød T, Mortensen ES, Eggen AE, Risberg T, Wist EA, Flote VG, Furberg AS, Wilsgaard T, Akslen LA, McTiernan A (2016)
Pre-diagnostic high-sensitive C-reactive protein and breast cancer risk, recurrence, and survival
Breast Cancer Res Treat, 155 (2), 345-54
DOI 10.1007/s10549-015-3671-1, PubMed 26740213

Hortobagyi GN, Stemmer SM, Burris HA, Yap YS, Sonke GS, Paluch-Shimon S, Campone M, Blackwell KL, André F, Winer EP, Janni W, Verma S, Conte P, Arteaga CL, Cameron DA, Petrakova K, Hart LL, Villanueva C, Chan A, Jakobsen E, Nusch A, Burdaeva O, Grischke EM, Alba E, Wist E et al. (2016)
Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer
N Engl J Med, 375 (18), 1738-1748
DOI 10.1056/NEJMoa1609709, PubMed 27717303

Reinertsen KV, Engebraaten O, Loge JH, Cvancarova M, Naume B, Wist E, Edvardsen H, Wille E, Bjøro T, Kiserud CE (2016)
Fatigue During and After Breast Cancer Therapy-A Prospective Study
J Pain Symptom Manage, 53 (3), 551-560
DOI 10.1016/j.jpainsymman.2016.09.011, PubMed 28042070

Publications 2015

Flote VG, Frydenberg H, Ursin G, Iversen A, Fagerland MW, Ellison PT, Wist EA, Egeland T, Wilsgaard T, McTiernan A, Furberg AS, Thune I (2015)
High-density lipoprotein-cholesterol, daily estradiol and progesterone, and mammographic density phenotypes in premenopausal women
Cancer Prev Res (Phila), 8 (6), 535-44
DOI 10.1158/1940-6207.CAPR-14-0267, PubMed 25804612

Publications 2014

Flote VG, Furberg AS, McTiernan A, Frydenberg H, Ursin G, Iversen A, Lofteroed T, Ellison PT, Wist EA, Egeland T, Wilsgaard T, Makar KW, Chang-Claude J, Thune I (2014)
Gene variations in oestrogen pathways, CYP19A1, daily 17β-estradiol and mammographic density phenotypes in premenopausal women
Breast Cancer Res, 16 (6), 499
DOI 10.1186/s13058-014-0499-2, PubMed 25522654

Naume B, Synnestvedt M, Falk RS, Wiedswang G, Weyde K, Risberg T, Kersten C, Mjaaland I, Vindi L, Sommer HH, Sætersdal AB, Rypdal MC, Bendigtsen Schirmer C, Wist EA, Borgen E (2014)
Clinical outcome with correlation to disseminated tumor cell (DTC) status after DTC-guided secondary adjuvant treatment with docetaxel in early breast cancer
J Clin Oncol, 32 (34), 3848-57
DOI 10.1200/JCO.2014.56.9327, PubMed 25366688

Rustøen T, Valeberg BT, Kolstad E, Wist E, Paul S, Miaskowski C (2014)
A randomized clinical trial of the efficacy of a self-care intervention to improve cancer pain management
Cancer Nurs, 37 (1), 34-43
DOI 10.1097/NCC.0b013e3182948418, PubMed 23666269

Publications 2012

Brydøy M, Fosså SD, Klepp O, Bremnes RM, Wist EA, Bjøro T, Wentzel-Larsen T, Dahl O, Norwegian Urology Cancer Group (NUCG) III study group (2012)
Sperm counts and endocrinological markers of spermatogenesis in long-term survivors of testicular cancer
Br J Cancer, 107 (11), 1833-9
DOI 10.1038/bjc.2012.471, PubMed 23169336

Rustøen T, Valeberg BT, Kolstad E, Wist E, Paul S, Miaskowski C (2012)
The PRO-SELF(©) Pain Control Program improves patients' knowledge of cancer pain management
J Pain Symptom Manage, 44 (3), 321-30
DOI 10.1016/j.jpainsymman.2011.09.015, PubMed 22704056

Synnestvedt M, Borgen E, Wist E, Wiedswang G, Weyde K, Risberg T, Kersten C, Mjaaland I, Vindi L, Schirmer C, Nesland JM, Naume B (2012)
Disseminated tumor cells as selection marker and monitoring tool for secondary adjuvant treatment in early breast cancer. Descriptive results from an intervention study
BMC Cancer, 12, 616
DOI 10.1186/1471-2407-12-616, PubMed 23259667

Wist EA, Mjaaland I, Løkkevik E, Sommer HH (2012)
Weekly Paclitaxel plus Capecitabine versus Docetaxel Every 3 Weeks plus Capecitabine in Metastatic Breast Cancer
J Oncol, 2012, 862921
DOI 10.1155/2012/862921, PubMed 22291703

Publications 2011

Hysing J, Wist E (2011)
Cardiotoxic effects of trastuzumab
Tidsskr Nor Laegeforen, 131 (22), 2239-41
DOI 10.4045/tidsskr.10.0862, PubMed 22085949

Reinertsen KV, Grenaker Alnæs GI, Landmark-Høyvik H, Loge JH, Wist E, Kristensen VN, Fosså SD, Edvardsen H (2011)
Fatigued breast cancer survivors and gene polymorphisms in the inflammatory pathway
Brain Behav Immun, 25 (7), 1376-83
DOI 10.1016/j.bbi.2011.04.001, PubMed 21496483

Publications 2010

Andersson M, Lidbrink E, Bjerre K, Wist E, Enevoldsen K, Jensen AB, Karlsson P, Tange UB, Sørensen PG, Møller S, Bergh J, Langkjer ST (2010)
Phase III randomized study comparing docetaxel plus trastuzumab with vinorelbine plus trastuzumab as first-line therapy of metastatic or locally advanced human epidermal growth factor receptor 2-positive breast cancer: the HERNATA study
J Clin Oncol, 29 (3), 264-71
DOI 10.1200/JCO.2010.30.8213, PubMed 21149659

Brydøy M, Fosså SD, Klepp O, Bremnes RM, Wist EA, Wentzel-Larsen T, Dahl O, Norwegian Urology Cancer Group III study group (2010)
Paternity and testicular function among testicular cancer survivors treated with two to four cycles of cisplatin-based chemotherapy
Eur Urol, 58 (1), 134-40
DOI 10.1016/j.eururo.2010.03.041, PubMed 20395037

Dahl CF, Haugnes HS, Bremnes R, Dahl O, Fosså SD, Klepp O, Wist E, Dahl AA (2010)
A controlled study of risk factors for disease and current problems in long-term testicular cancer survivors
J Cancer Surviv, 4 (3), 256-65
DOI 10.1007/s11764-010-0133-y, PubMed 20574815

Reinertsen KV, Cvancarova M, Loge JH, Edvardsen H, Wist E, Fosså SD (2010)
Predictors and course of chronic fatigue in long-term breast cancer survivors
J Cancer Surviv, 4 (4), 405-14
DOI 10.1007/s11764-010-0145-7, PubMed 20862614

Rutskij R, Gaarden T, Bremnes R, Dahl O, Finset A, Fossa SD, Klepp O, Sorebo O, Wist E, Dahl AA (2010)
A study of coping in long-term testicular cancer survivors
Psychol Health Med, 15 (2), 146-58
DOI 10.1080/13548501003623955, PubMed 20391232

Wist EA (2010)
In Kreftsykepleie pasient - utfordring - handling, Akribe Forlag, Oslo, Norge, 431-439
PublikaID 78, ISBN 978-82-7950-144-2

Publications 2009

Brydøy M, Oldenburg J, Klepp O, Bremnes RM, Wist EA, Wentzel-Larsen T, Hauge ER, Dahl O, Fosså SD (2009)
Observational study of prevalence of long-term Raynaud-like phenomena and neurological side effects in testicular cancer survivors
J Natl Cancer Inst, 101 (24), 1682-95
DOI 10.1093/jnci/djp413, PubMed 19940282

Finstad SE, Emaus A, Tretli S, Jasienska G, Ellison PT, Furberg AS, Wist EA, Thune I (2009)
Adult height, insulin, and 17beta-estradiol in young women
Cancer Epidemiol Biomarkers Prev, 18 (5), 1477-83
DOI 10.1158/1055-9965.EPI-08-0972, PubMed 19423524

Grov EK, Fosså SD, Bremnes RM, Dahl O, Klepp O, Wist E, Dahl AA (2009)
The personality trait of neuroticism is strongly associated with long-term morbidity in testicular cancer survivors
Acta Oncol, 48 (6), 842-9
DOI 10.1080/02841860902795232, PubMed 19412812

Kalager M, Kåresen R, Wist E (2009)
[Survival after breast cancer--differences between Norwegian counties]
Tidsskr Nor Laegeforen, 129 (24), 2595-600
DOI 10.4045/tidsskr.09.0024, PubMed 20029554

Kåresen R, Wist E (2009)
Kreftsykdommer: en basisbok for helsepersonell
Gyldendal akademisk, Oslo (3. utg.), 441 s.
BIBSYS 080553532, ISBN 978-82-05-38485-9

Reinertsen KV, Cvancarova M, Wist E, Bjøro T, Dahl AA, Danielsen T, Fosså SD (2009)
Thyroid function in women after multimodal treatment for breast cancer stage II/III: comparison with controls from a population sample
Int J Radiat Oncol Biol Phys, 75 (3), 764-70
DOI 10.1016/j.ijrobp.2008.11.037, PubMed 19286332

Skaali T, Fosså SD, Bremnes R, Dahl O, Haaland CF, Hauge ER, Klepp O, Oldenburg J, Wist E, Dahl AA (2009)
Fear of recurrence in long-term testicular cancer survivors
Psychooncology, 18 (6), 580-8
DOI 10.1002/pon.1437, PubMed 18855944

Wist EA, Naume B (2009)
In Medikamentell kreftbehandling, Farmakologisk institutt, Det medisinske fakultet, Universitetet i Oslo, 357-362
PublikaID 79, ISBN 978-829923312-5

Publications 2008

Haugnes HS, Aass N, Fosså SD, Dahl O, Klepp O, Wist EA, Wilsgaard T, Bremnes RM (2008)
Predicted cardiovascular mortality and reported cardiovascular morbidity in testicular cancer survivors
J Cancer Surviv, 2 (3), 128-37
DOI 10.1007/s11764-008-0054-1, PubMed 18792787

Orre IJ, Fosså SD, Murison R, Bremnes R, Dahl O, Klepp O, Loge JH, Wist E, Dahl AA (2008)
Chronic cancer-related fatigue in long-term survivors of testicular cancer
J Psychosom Res, 64 (4), 363-71
DOI 10.1016/j.jpsychores.2008.01.002, PubMed 18374735

Wist E, Oz M, Roizen MF (2008)
Pantagruel forl., Oslo, 96 s.
BIBSYS 082709505, ISBN 978-82-7900-331-1

Publications 2007

Dahl AA, Bremnes R, Dahl O, Klepp O, Wist E, Fosså SD (2007)
Is the sexual function compromised in long-term testicular cancer survivors?
Eur Urol, 52 (5), 1438-47
DOI 10.1016/j.eururo.2007.02.046, PubMed 17350159

Norum J, Olsen JA, Wist EA, Lønning PE (2007)
Trastuzumab in adjuvant breast cancer therapy. A model based cost-effectiveness analysis
Acta Oncol, 46 (2), 153-64
DOI 10.1080/02841860601096841, PubMed 17453363

Risberg T, Nilsen OG, Wist E (2007)
Alternativ og komplementær behandling
In Palliasjon: nordisk lærebok, Gyldendal akademisk, Oslo, S. 179-193
BIBSYS 080210201

Smith I, Procter M, Gelber RD, Guillaume S, Feyereislova A, Dowsett M, Goldhirsch A, Untch M, Mariani G, Baselga J, Kaufmann M, Cameron D, Bell R, Bergh J, Coleman R, Wardley A, Harbeck N, Lopez RI, Mallmann P, Gelmon K, Wilcken N, Wist E, Sánchez Rovira P, Piccart-Gebhart MJ, HERA study team (2007)
2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial
Lancet, 369 (9555), 29-36
DOI 10.1016/S0140-6736(07)60028-2, PubMed 17208639

Wilking N, Lidbrink E, Wiklund T, Erikstein B, Lindman H, Malmström P, Kellokumpu-Lehtinen P, Bengtsson NO, Söderlund G, Anker G, Wist E, Ottosson S, Salminen E, Ljungman P, Holte H, Nilsson J, Blomqvist C, Bergh J (2007)
Long-term follow-up of the SBG 9401 study comparing tailored FEC-based therapy versus marrow-supported high-dose therapy
Ann Oncol, 18 (4), 694-700
DOI 10.1093/annonc/mdl488, PubMed 17301072

Publications 2006

Drageset V, Nesland JM, Erikstein B, Skovlund E, Sommer H, Anker G, Wist E, Lundgren S, Bergh J, Kvalheim G (2006)
Monitoring of disseminated tumor cells in bone marrow in high-risk breast cancer patients treated with high-dose chemotherapy
Int J Cancer, 118 (11), 2877-81
DOI 10.1002/ijc.21709, PubMed 16381016

Haugnes HS, Aass N, Fosså SD, Dahl O, Klepp O, Wist EA, Svartberg J, Wilsgaard T, Bremnes RM (2006)
Components of the metabolic syndrome in long-term survivors of testicular cancer
Ann Oncol, 18 (2), 241-8
DOI 10.1093/annonc/mdl372, PubMed 17060482

Publications 2005

Brydøy M, Fosså SD, Klepp O, Bremnes RM, Wist EA, Wentzel-Larsen T, Dahl O (2005)
Paternity following treatment for testicular cancer
J Natl Cancer Inst, 97 (21), 1580-8
DOI 10.1093/jnci/dji339, PubMed 16264178

Dahl AA, Haaland CF, Mykletun A, Bremnes R, Dahl O, Klepp O, Wist E, Fosså SD (2005)
Study of anxiety disorder and depression in long-term survivors of testicular cancer
J Clin Oncol, 23 (10), 2389-95
DOI 10.1200/JCO.2005.05.061, PubMed 15800331

Kåresen R, Wist E (2005)
Kreftsykdommer: en basisbok for helsepersonell
Gyldendal akademisk, Oslo (2. utg.), 416 s.
BIBSYS 050216910, ISBN 978-82-05-33494-6

Mykletun A, Dahl AA, Haaland CF, Bremnes R, Dahl O, Klepp O, Wist E, Fosså SD (2005)
Side effects and cancer-related stress determine quality of life in long-term survivors of testicular cancer
J Clin Oncol, 23 (13), 3061-8
DOI 10.1200/JCO.2005.08.048, PubMed 15860864

Sagstuen H, Aass N, Fosså SD, Dahl O, Klepp O, Wist EA, Wilsgaard T, Bremnes RM (2005)
Blood pressure and body mass index in long-term survivors of testicular cancer
J Clin Oncol, 23 (22), 4980-90
DOI 10.1200/JCO.2005.06.882, PubMed 16051950

Thorsen L, Nystad W, Stigum H, Dahl O, Klepp O, Bremnes RM, Wist E, Fosså SD (2005)
The association between self-reported physical activity and prevalence of depression and anxiety disorder in long-term survivors of testicular cancer and men in a general population sample
Support Care Cancer, 13 (8), 637-46
DOI 10.1007/s00520-004-0769-0, PubMed 15756585

Wist EA (2005)
Onkologiske akuttilstander
In Kreftsykdommer - en basisbok for helsepersonell (Wist EA, ed.), Gyldendal Akademisk, Oslo, Norway
PublikaID 80, ISBN 82-05-33494-3

Publications 2004

Kolstad A, Risberg T, Bremnes Y, Wilsgaard T, Holte H, Klepp O, Mella O, Wist E (2004)
Use of complementary and alternative therapies: a national multicentre study of oncology health professionals in Norway
Support Care Cancer, 12 (5), 312-8
DOI 10.1007/s00520-004-0590-9, PubMed 14767750

Risberg T, Bremnes Y, Kolstad A, Holte H, Wist E, Mella O, Klepp O (2004)
[Should complementary therapies be offered in hospitals?]
Tidsskr Nor Laegeforen, 124 (23), 3078-80
PubMed 15586193

Risberg T, Kolstad A, Bremnes Y, Holte H, Wist EA, Mella O, Klepp O, Wilsgaard T, Cassileth BR (2004)
Knowledge of and attitudes toward complementary and alternative therapies; a national multicentre study of oncology professionals in Norway
Eur J Cancer, 40 (4), 529-35
DOI 10.1016/j.ejca.2003.11.011, PubMed 14962719

Wist EA, Sommer HH, Ostenstad B, Risberg T, Bremnes Y, Mjaaland I (2004)
Oral capecitabine in anthracycline- and taxane-pretreated advanced/metastatic breast cancer
Acta Oncol, 43 (2), 186-9
DOI 10.1080/02841860310023165, PubMed 15163168

Wist EA, Sommer HH, Ostenstad B, Risberg T, Fjaestad K (2004)
Weekly one-hour paclitaxel as first-line chemotherapy for metastatic breast cancer
Acta Oncol, 43 (1), 11-4
DOI 10.1080/02841860310017748, PubMed 15068314

Publications 2003

Nord C, Bjøro T, Ellingsen D, Mykletun A, Dahl O, Klepp O, Bremnes RM, Wist E, Fosså SD (2003)
Gonadal hormones in long-term survivors 10 years after treatment for unilateral testicular cancer
Eur Urol, 44 (3), 322-8
DOI 10.1016/s0302-2838(03)00263-x, PubMed 12932930

Risberg T, Bremnes RM, Vickers A, Wist EA, Kaasa S (2003)
[Does use of alternative medicine aggravate the survival prognosis in cancer?]
Tidsskr Nor Laegeforen, 123 (5), 628-30
PubMed 12683189

Risberg T, Kolstad A, Wist EA, Holte H, Mella O, Klepp O (2003)
[Should alternative therapists treat cancer--what is the opinion of oncology health personnel?]
Tidsskr Nor Laegeforen, 123 (21), 3059-61
PubMed 14618177

Risberg T, Vickers A, Bremnes RM, Wist EA, Kaasa S, Cassileth BR (2003)
Does use of alternative medicine predict survival from cancer?
Eur J Cancer, 39 (3), 372-7
DOI 10.1016/s0959-8049(02)00701-3, PubMed 12565991

Thorsen L, Nystad W, Dahl O, Klepp O, Bremnes RM, Wist E, Fosså SD (2003)
The level of physical activity in long-term survivors of testicular cancer
Eur J Cancer, 39 (9), 1216-21
DOI 10.1016/s0959-8049(03)00151-5, PubMed 12763208

Publications 2002

Luoma ML, Hakamies-Blomqvist L, Sjöström J, Mouridsen H, Pluzanska A, Malmström P, Bengtsson NO, Hultborn R, Ostenstaad B, Mjaaland I, Valvere V, Wist E, Baldursson G, Ahigren J, Blomqvist C (2002)
Physical performance, toxicity, and quality of life as assessed by the physician and the patient
Acta Oncol, 41 (1), 44-9
DOI 10.1080/028418602317314055, PubMed 11990517

Sjöström J, Blomqvist C, von Boguslawski K, Bengtsson NO, Mjaaland I, Malmström P, Ostenstadt B, Wist E, Valvere V, Takayama S, Reed JC, Saksela E (2002)
The predictive value of bcl-2, bax, bcl-xL, bag-1, fas, and fasL for chemotherapy response in advanced breast cancer
Clin Cancer Res, 8 (3), 811-6
PubMed 11895913

Sjöström J, Collan J, von Boguslawski K, Franssila K, Bengtsson NO, Mjaaland I, Malmström P, Østenstad B, Wist E, Valvere V, Bergh J, Skiöld-Petterson D, Saksela E, Blomqvist C (2002)
C-erbB-2 expression does not predict response to docetaxel or sequential methotrexate and 5-fluorouracil in advanced breast cancer
Eur J Cancer, 38 (4), 535-42
DOI 10.1016/s0959-8049(01)00403-8, PubMed 11872346

Tveit KM, Wist E, Wiig JN (2002)
Tarmkreft: informasjon om tarmkreft for pasienter pårørende og andreinteresserte
In Kreftinfo, Den norske kreftforening, Oslo, 6/2002 (4. oppl.), 25 s.
BIBSYS 030466571

Tynninen O, Sjöström J, von Boguslawski K, Bengtsson NO, Heikkilä R, Malmström P, Ostenstad B, Wist E, Valvere V, Saksela E, Paavonen T, Blomqvist C (2002)
Tumour microvessel density as predictor of chemotherapy response in breast cancer patients
Br J Cancer, 86 (12), 1905-8
DOI 10.1038/sj.bjc.6600325, PubMed 12085184

Publications 2001

Dueland S, Wist E, Løberg M, Iversen J (2001)
Cutaneous relapse of testicular embryonic carcinoma
J Urol, 165 (3), 909
DOI 10.1016/S0022-5347(05)66565-2, PubMed 11176507

Melsom H, Wist E (2001)
[Terminal care of cancer patients]
Tidsskr Nor Laegeforen, 121 (22), 2590-2
PubMed 11668754

Wist E (2001)
[Is comorbidity a prognostic factor in premenopausal women with breast cancer?]
Tidsskr Nor Laegeforen, 121 (9), 1023
PubMed 11354873

Publications 2000

Bergh J, Wiklund T, Erikstein B, Lidbrink E, Lindman H, Malmström P, Kellokumpu-Lehtinen P, Bengtsson NO, Söderlund G, Anker G, Wist E, Ottosson S, Salminen E, Ljungman P, Holte H, Nilsson J, Blomqvist C, Wilking N (2000)
Tailored fluorouracil, epirubicin, and cyclophosphamide compared with marrow-supported high-dose chemotherapy as adjuvant treatment for high-risk breast cancer: a randomised trial. Scandinavian Breast Group 9401 study
Lancet, 356 (9239), 1384-91
DOI 10.1016/s0140-6736(00)02841-5, PubMed 11052580

Kåresen R, Wist E (2000)
Kreftsykdommer: en basisbok for helsepersonell
Gyldendal akademisk, Oslo, 400 s.
BIBSYS 000586978, ISBN 82-00-45260-3

Sjöström J, Blomqvist C, Heikkilä P, Boguslawski KV, Räisänen-Sokolowski A, Bengtsson NO, Mjaaland I, Malmström P, Ostenstadt B, Bergh J, Wist E, Valvere V, Saksela E (2000)
Predictive value of p53, mdm-2, p21, and mib-1 for chemotherapy response in advanced breast cancer
Clin Cancer Res, 6 (8), 3103-10
PubMed 10955790

Publications 1999

Sjöström J, Blomqvist C, Mouridsen H, Pluzanska A, Ottosson-Lönn S, Bengtsson NO, Ostenstad B, Mjaaland I, Palm-Sjövall M, Wist E, Valvere V, Anderson H, Bergh J (1999)
Docetaxel compared with sequential methotrexate and 5-fluorouracil in patients with advanced breast cancer after anthracycline failure: a randomised phase III study with crossover on progression by the Scandinavian Breast Group
Eur J Cancer, 35 (8), 1194-201
DOI 10.1016/s0959-8049(99)00122-7, PubMed 10615229

Wist E (1999)
[Well-educated and healthy]
Tidsskr Nor Laegeforen, 119 (11), 1576
PubMed 10385797

Publications 1998

Haarstad H, Lønning PE, Gundersen S, Wist E, Raabe N, Kvinnsland S (1998)
Influence of droloxifene on metastatic breast cancer as first-line endocrine treatment
Acta Oncol, 37 (4), 365-8
DOI 10.1080/028418698430584, PubMed 9743458

Jungnelius U, Ringborg U, Aamdal S, Mattsson J, Stierner U, Ingvar C, Malmström P, Andersson R, Karlsson M, Willman K, Wist E, Bjelkengren G, Westberg R (1998)
Dacarbazine-vindesine versus dacarbazine-vindesine-cisplatin in disseminated malignant melanoma. A randomised phase III trial
Eur J Cancer, 34 (9), 1368-74
DOI 10.1016/s0959-8049(98)00068-9, PubMed 9849419

Kåresen R, Schlichting E, Wist E (1998)
Brystkreft: en informasjonsbok for pasienter og pårørende
Universitetsforl., Oslo, 170 s.
BIBSYS 982362595, ISBN 82-00-42576-2

Risberg T, Lund E, Wist E, Kaasa S, Wilsgaard T (1998)
Cancer patients use of nonproven therapy: a 5-year follow-up study
J Clin Oncol, 16 (1), 6-12
DOI 10.1200/JCO.1998.16.1.6, PubMed 9440716

Risberg T, Wist E, Bremnes RM (1998)
Patients' opinion and use of non-proven therapies related to their view on cancer aetiology
Anticancer Res, 18 (1B), 499-505
PubMed 9568169

Sørbye SW, Risberg T, Norum J, Wist EA (1998)
[Cancer patients' perception of the examination period prior to treatment]
Tidsskr Nor Laegeforen, 118 (16), 2468-70
PubMed 9667121

Publications 1997

Klepp O, Dahl O, Flodgren P, Stierner U, Olsson AM, Oldbring J, Nilsson S, Daehlin L, Tørnblom M, Småland R, Starkhammar H, Abramsson L, Wist E, Raabe N, Edekling T, Cavallin-Ståhl E (1997)
Risk-adapted treatment of clinical stage 1 non-seminoma testis cancer
Eur J Cancer, 33 (7), 1038-44
DOI 10.1016/s0959-8049(97)00041-5, PubMed 9376184

Norum J, Olsen JA, Wist EA (1997)
Lumpectomy or mastectomy? Is breast conserving surgery too expensive?
Breast Cancer Res Treat, 45 (1), 7-14
DOI 10.1023/a:1005804101106, PubMed 9285112

Norum J, Wist E (1997)
[Hodgkin disease treated at the Tromsø regional hospital 1985-93. Diagnosis, treatment, prognosis, quality of life and costs of a decentralized treatment]
Tidsskr Nor Laegeforen, 117 (1), 23-6
PubMed 9064805

Norum J, Wist E (1997)
[Breast cancer treated at the oncologic department, University Hospital in Tromsø 1986-94]
Tidsskr Nor Laegeforen, 117 (26), 3786-9
PubMed 9417681

Risberg T, Bremnes RM, Wist E, Kaasa S, Jacobsen BK (1997)
Communicating with and treating cancer patients: how does the use of non-proven therapies and patients' feeling of mental distress influence the interaction between the patient and the hospital staff
Eur J Cancer, 33 (6), 883-90
DOI 10.1016/s0959-8049(97)00025-7, PubMed 9291810

Risberg T, Kaasa S, Wist E, Melsom H (1997)
Why are cancer patients using non-proven complementary therapies? A cross-sectional multicentre study in Norway
Eur J Cancer, 33 (4), 575-80
DOI 10.1016/s0959-8049(96)00504-7, PubMed 9274437

Risberg T, Wist E, Melsom H, Kaasa S (1997)
[Use of alternative medicine among Norwegian hospitalized cancer patients]
Tidsskr Nor Laegeforen, 117 (17), 2458-63
PubMed 9265305

Saeter G, Alvegård TA, Monge OR, Strander H, Turesson I, Klepp R, Söderberg M, Wist E, Raabe N, Erlanson M, Solheim OP, Hannisdal E (1997)
Ifosfamide and continuous infusion etoposide in advanced adult soft tissue sarcoma. A Scandinavian Sarcoma Group Phase II Study
Eur J Cancer, 33 (10), 1551-8
DOI 10.1016/s0959-8049(97)00102-0, PubMed 9389914

Tveit KM, Guldvog I, Hagen S, Trondsen E, Harbitz T, Nygaard K, Nilsen JB, Wist E, Hannisdal E (1997)
Randomized controlled trial of postoperative radiotherapy and short-term time-scheduled 5-fluorouracil against surgery alone in the treatment of Dukes B and C rectal cancer. Norwegian Adjuvant Rectal Cancer Project Group
Br J Surg, 84 (8), 1130-5
DOI 10.1002/bjs.1800840827, PubMed 9278661

Publications 1996

Bremnes RM, Wist EA (1996)
Palliative chemotherapy in metastatic colorectal carcinoma: comparison of two chemotherapeutic regimens
Anticancer Res, 16 (2), 921-6
PubMed 8687152

Bremnes RM, Wist EA, Andersen K (1996)
[Attitudes to treatment with cytostatic agents. Do cancer patients, physicians, nurses and healthy individuals vary in their views?]
Tidsskr Nor Laegeforen, 116 (21), 2583-7
PubMed 8928131

Holte H, Kvaløy SO, Engan T, Evensen SA, Mella O, Tangen JM, Wesenberg F, Wist EA (1996)
[High dose therapy with autologous stem cell support in malignant disorders. Excerpt from the statement by the advisory group of the State Health Services]
Tidsskr Nor Laegeforen, 116 (21), 2577-81
PubMed 8928130

Holte H, Mella O, Wist E, Telhaug R, Hannisdal E, Abrahamsen AF (1996)
ChlVPP is as effective as alternating ChlVPP/ABOD in advanced stage Hodgkin's disease
Acta Oncol, 35 Suppl 8, 73-80
DOI 10.3109/02841869609098523, PubMed 9073051

Kaasa S, Klepp O, Hagen S, Wist E, Kvinnsland S (1996)
Treatment intention in hospitalized cancer patients in oncological wards in Norway: a national survey
Cancer Treat Rev, 22 Suppl A, 33-9
DOI 10.1016/s0305-7372(96)90061-4, PubMed 8625347

Kaasa S, Wist E, Høst H (1996)
Palliativ strålbehandling
Studentlitteratur, Lund, 189 s.
BIBSYS 962432091, ISBN 91-44-39771-2

Norum J, Angelsen V, Wist E, Olsen JA (1996)
Treatment costs in Hodgkin's disease: a cost-utility analysis
Eur J Cancer, 32A (9), 1510-7
DOI 10.1016/0959-8049(96)00142-6, PubMed 8911110

Norum J, Wist E (1996)
Psychological distress in survivors of Hodgkin's disease
Support Care Cancer, 4 (3), 191-5
DOI 10.1007/BF01682339, PubMed 8739651

Norum J, Wist E (1996)
Delay in diagnosis and treatment of breast cancer in northern Norway
Oncol Rep, 3 (3), 571-4
DOI 10.3892/or.3.3.571, PubMed 21594415

Norum J, Wist E, Jerome CP (1996)
Gd-DTPA enhanced MR imaging in the management of residual mediastinal tumours in malignant lymphoma and thymoma
Cancer J., 9 (1), 56-57

Norum J, Wist EA (1996)
Quality of life in survivors of Hodgkin's disease
Qual Life Res, 5 (3), 367-74
DOI 10.1007/BF00433921, PubMed 8763805

Risberg T, Sørbye SW, Norum J, Wist EA (1996)
Diagnostic delay causes more psychological distress in female than in male cancer patients
Anticancer Res, 16 (2), 995-9
PubMed 8687166

Risberg T, Wist E, Kaasa S, Lund E, Norum J (1996)
Spiritual healing among Norwegian hospitalised cancer patients and patients' religious needs and preferences of pastoral services
Eur J Cancer, 32A (2), 274-81
DOI 10.1016/0959-8049(95)00516-1, PubMed 8664041

Publications 1995

Bremnes RM, Andersen K, Wist EA (1995)
Cancer patients, doctors and nurses vary in their willingness to undertake cancer chemotherapy
Eur J Cancer, 31A (12), 1955-9
DOI 10.1016/0959-8049(95)00513-7, PubMed 8562147

Kaasa S, Bjordal K, Aaronson N, Moum T, Wist E, Hagen S, Kvikstad A (1995)
The EORTC core quality of life questionnaire (QLQ-C30): validity and reliability when analysed with patients treated with palliative radiotherapy
Eur J Cancer, 31A (13-14), 2260-3
DOI 10.1016/0959-8049(95)00296-0, PubMed 8652253

Norum J, Nordøy T, Wist E (1995)
Testicular cancer treated in a minor general oncology department
Eur J Cancer, 31A (3), 293-5
DOI 10.1016/0959-8049(94)00448-e, PubMed 7540400

Norum J, Wist E, Nordøy T, Due J (1995)
[Testicular cancer treated at the regional hospital in Tromsø 1985-1993]
Tidsskr Nor Laegeforen, 115 (14), 1715-7
PubMed 7785028

Norum J, Wist E, Nordøy T, Stalsberg H (1995)
Subclassification of Hodgkin's disease, nodular sclerosis type. Prognostic value?
Anticancer Res, 15 (4), 1569-72
PubMed 7654047

Risberg T, Lund E, Wist E (1995)
Use of non-proven therapies. Differences in attitudes between Norwegian patients with non-malignant disease and patients suffering from cancer
Acta Oncol, 34 (7), 893-8
DOI 10.3109/02841869509127201, PubMed 7492377

Risberg T, Lund E, Wist E, Dahl O, Sundstrøm S, Andersen OK, Kaasa S (1995)
The use of non-proven therapy among patients treated in Norwegian oncological departments. A cross-sectional national multicentre study
Eur J Cancer, 31A (11), 1785-9
DOI 10.1016/0959-8049(95)00328-g, PubMed 8541101

Wist E (1995)
CD e RiTøelt: RiTø-revyen 1995
[Regionsykehuset i Tromsø], [Tromsø], 60 s.
BIBSYS 092366422

Publications 1994

Gundersen S, Hannisdal E, Lundgren S, Wist E (1994)
Weekly doxorubicin with or without high-dose medroxyprogesterone acetate in hormone-resistant advanced breast cancer. A randomised study. The Norwegian Breast Cancer Group
Eur J Cancer, 30A (12), 1775-8
DOI 10.1016/0959-8049(94)00213-o, PubMed 7880604

Norum J, Bremnes RM, Wist E (1994)
The Ch1VPP regimen, a risk factor for herpes zoster virus infection in patients treated for Hodgkin's disease
Eur J Haematol, 53 (1), 51-3
DOI 10.1111/j.1600-0609.1994.tb00180.x, PubMed 8062898

Publications 1993

Klemetsdal B, Straume B, Wist E, Aarbakke J (1993)
Identification of factors regulating thiopurine methyltransferase activity in a Norwegian population
Eur J Clin Pharmacol, 44 (2), 147-52
DOI 10.1007/BF00315472, PubMed 8453958

Klemetsdal B, Wist E, Aarbakke J (1993)
Gender difference in red blood cell thiopurine methyltransferase activity
Scand J Clin Lab Invest, 53 (7), 747-9
DOI 10.3109/00365519309092580, PubMed 8272762

Kaasa S, Malt U, Hagen S, Wist E, Moum T, Kvikstad A (1993)
Psychological distress in cancer patients with advanced disease
Radiother Oncol, 27 (3), 193-7
DOI 10.1016/0167-8140(93)90073-h, PubMed 7692472

Norum J, Wist E (1993)
Treatment of Hodgkin's disease in a small oncological unit
Eur J Haematol, 50 (5), 297-8
DOI 10.1111/j.1600-0609.1993.tb00166.x, PubMed 8319791

Norum J, Wist E (1993)
[When a cancer patient dies at home--experience of the relatives]
Tidsskr Nor Laegeforen, 113 (9), 1107-9
PubMed 8493682

Wist E (1993)
[Spontaneous cancer remission]
Tidsskr Nor Laegeforen, 113 (12), 1497-8
PubMed 8332985

Wist E (1993)
Teaching communication with cancer patients and terminally ill patients to medical students
J Cancer Educ, 8 (2), 119-22
DOI 10.1080/08858199309528217, PubMed 8363937

Wist E (1993)
Stråleterapi i Norge: innstilling avgitt 17.3.92
In Helsedirektoratets utredningsserie, [Direktoratet], [Oslo], 2-93, 37 s.
BIBSYS 931341388

Wist E, Risberg T (1993)
Topical capsaicin in treatment of hyperalgesia, allodynia and dysesthetic pain caused by malignant tumour infiltration of the skin
Acta Oncol, 32 (3), 343
DOI 10.3109/02841869309093606, PubMed 8323774

Publications 1992

Fønnebø V, Wist E (1992)
[Admission criteria for medical studies]
Tidsskr Nor Laegeforen, 112 (10), 1338
PubMed 1579925

Haarstad H, Gundersen S, Wist E, Raabe N, Mella O, Kvinnsland S (1992)
Droloxifene--a new anti-estrogen. A phase II study in advanced breast cancer
Acta Oncol, 31 (4), 425-8
DOI 10.3109/02841869209088284, PubMed 1632978

Klemetsdal B, Tollefsen E, Loennechen T, Johnsen K, Utsi E, Gisholt K, Wist E, Aarbakke J (1992)
Interethnic difference in thiopurine methyltransferase activity
Clin Pharmacol Ther, 51 (1), 24-31
DOI 10.1038/clpt.1992.4, PubMed 1732075

Kaasa S, Wist E, Høst H (1992)
Palliativ strålebehandling
Universitetsforlaget, Oslo, 179 s.
BIBSYS 921112025, ISBN 82-00-40691-1

Norum J, Wist E (1992)
[Accidents with radioactive pollution. Can we do something?]
Tidsskr Nor Laegeforen, 112 (10), 1314-6
PubMed 1374574

Norum J, Wist E (1992)
[Treatment of advanced anal cancer]
Nord Med, 107 (8-9), 227-8
PubMed 1408730

Norum J, Wist E (1992)
[Intestinal lymphoma presented as multiple intestinal polyposis]
Tidsskr Nor Laegeforen, 112 (15), 1956-7
PubMed 1509456

Publications 1991

Bremnes RM, Smeland E, Slørdal L, Wist E, Aarbakke J (1991)
The effect of vindesine on methotrexate hydroxylation in the rat
Biochem Pharmacol, 42 (8), 1561-8
DOI 10.1016/0006-2952(91)90425-5, PubMed 1930283

Bremnes RM, Smeland E, Willassen NP, Wist E, Aarbakke J (1991)
Inhibition of 7-hydroxymethotrexate formation by amsacrine
Cancer Chemother Pharmacol, 28 (5), 377-83
DOI 10.1007/BF00685693, PubMed 1914082

Kaasa S, Thorud E, Tausjø J, Wist E, Evensen JF, Gundersen S, Høst H (1991)
Phase I/II study of carboplatin and 5-fluorouracil in patients with advanced head and neck carcinoma
Eur J Cancer, 27 (5), 576-9
DOI 10.1016/0277-5379(91)90221-x, PubMed 1828964

Norum J, Wist E (1991)
[Infusor--an aid in cytostatic therapy]
Tidsskr Nor Laegeforen, 111 (16), 1979-80
PubMed 1866732

Norum J, Wist E, Bostad L (1991)
Incomplete Currarino syndrome with a presacral leiomyosarcoma
Acta Oncol, 30 (8), 987-8
DOI 10.3109/02841869109088256, PubMed 1777251

Norum J, Wist E, Bostad L (1991)
[Merkel cell carcinoma]
Tidsskr Nor Laegeforen, 111 (14), 1723-4
PubMed 2063380

Norum J, Wist E, Dahl IM (1991)
Cerebral metastases from multiple myeloma
Acta Oncol, 30 (7), 868-9
DOI 10.3109/02841869109091837, PubMed 1764277

Wist E, Risberg T (1991)
Trofosfamide in non-Hodgkin's lymphoma. A phase II study
Acta Oncol, 30 (7), 819-21
DOI 10.3109/02841869109091828, PubMed 1764273

Publications 1990

Norum J, Wist E (1990)
[Cerebral metastasis in Hodgkin's disease]
Tidsskr Nor Laegeforen, 110 (25), 3240-1
PubMed 2256037

Norum J, Wist E, Aasebø U (1990)
Tidsskr Nor Laegeforen, 110 (23), 3017-8
PubMed 2237855

Wist E (1990)
[Alltime pain relief?]
Tidsskr Nor Laegeforen, 110 (5), 581
PubMed 1689876

Publications 1989

Brada M, Ashley S, Nicholls J, Wist E, Colman M, McElwain TJ, Selby P, Peckham MJ, Horwich A (1989)
Stage III Hodgkin's disease--long-term results following chemotherapy, radiotherapy and combined modality therapy
Radiother Oncol, 14 (3), 185-98
DOI 10.1016/0167-8140(89)90166-7, PubMed 2710949

Bremnes RM, Slørdal L, Wist E, Aarbakke J (1989)
Formation and elimination of 7-hydroxymethotrexate in the rat in vivo after methotrexate administration
Cancer Res, 49 (9), 2460-4
PubMed 2706634

Bremnes RM, Slørdal L, Wist E, Aarbakke J (1989)
Dose-dependent pharmacokinetics of methotrexate and 7-hydroxymethotrexate in the rat in vivo
Cancer Res, 49 (22), 6359-64
PubMed 2804982

Publications 1988

Wist E, Kaasa S, Thorud E (1988)
[High dose melphalan and autologous bone marrow transplantation in the treatment of small cell carcinoma of the lung]
Tidsskr Nor Laegeforen, 108 (27), 2271-4
PubMed 2849815

Publications 1987

Vermund H, Jacobsen AB, Kaalhus O, Levernes S, Melsom H, Tausjø J, Thorud E, Thorvik J, Winther F, Wist E (1987)
Changing aspects in the treatment of squamous cell carcinoma of the oral tongue
Acta Oncol, 26 (3), 163-72
DOI 10.3109/02841868709091424, PubMed 3651261

Wist E (1987)
[How do physicians deliver sad messages?]
Nord Med, 102 (11), 321-2
PubMed 3697052

Publications 1986

Tretli S, Eide TJ, Wist E (1986)
Kreftforekomst i Nord-Norge
Kreftregisteret, Oslo, 120 s.
BIBSYS 874051134, ISBN 82-90343-15-9

Wist E, Melsom H, Vermund H, Winther F (1986)
[Treatment of advanced squamous cell carcinoma of the maxillary sinus]
Tidsskr Nor Laegeforen, 106 (7), 572-6
PubMed 3961784

Publications 1985

Wist E, Solheim OP, Jacobsen AB, Blom P (1985)
Primary retroperitoneal sarcomas. A review of 36 cases
Acta Radiol Oncol, 24 (4), 305-10
DOI 10.3109/02841868509136056, PubMed 2994385

Wist EA (1985)
Effect of the radioprotector WR 2721 on the response of metastatic Lewis lung carcinoma colonies to alkylating agents
Acta Radiol Oncol, 24 (3), 259-62
DOI 10.3109/02841868509134397, PubMed 2994377

Publications 1984

Wist E, Solheim OP (1984)
[Kaposi's sarcoma]
Tidsskr Nor Laegeforen, 104 (7), 495-8
PubMed 6729784

Wist EA, von Krogh J, Ous S (1984)
[Pelvic lipomatosis]
Tidsskr Nor Laegeforen, 104 (17-18), 1228-9
PubMed 6740618

Publications 1982

Millar JL, McElwain TJ, Clutterbuck RD, Wist EA (1982)
The modification of melphalan toxicity in tumor bearing mice by s-2-(3-aminopropylamino)- ethylphosphorothioic acid (WR 2721)
Am J Clin Oncol, 5 (3), 321-8
DOI 10.1097/00000421-198206000-00015, PubMed 6282111

Millar JL, Stephens TC, Wist EA (1982)
An explanation for the ability of cytotoxic drug pretreatment to reduce bone marrow related lethality of total body irradiation (TBI)
Int J Radiat Oncol Biol Phys, 8 (3-4), 581-3
DOI 10.1016/0360-3016(82)90688-5, PubMed 7050041

Spooner D, Bugden RD, Peckham MJ, Wist EA (1982)
The combination of 5-fluorouracil with misonidazole in patients with advanced colorectal cancer
Int J Radiat Oncol Biol Phys, 8 (3-4), 387-9
DOI 10.1016/0360-3016(82)90645-9, PubMed 7107357

Wist E (1982)
[Pathological liver function tests due to trimethoprim-sulfamethoxazole]
Tidsskr Nor Laegeforen, 102 (22), 1080-1
PubMed 7164063

Publications 1981

Krokan H, Wist E, Krokan RH (1981)
Aphidicolin inhibits DNA synthesis by DNA polymerase alpha and isolated nuclei by a similar mechanism
Nucleic Acids Res, 9 (18), 4709-19
DOI 10.1093/nar/9.18.4709, PubMed 6795595

Wist E, Millar JL, Shorthouse AJ (1981)
Melphalan uptake in relation to vascular and extracellular space of human lung-tumour xenografts
Br J Cancer, 43 (4), 458-63
DOI 10.1038/bjc.1981.67, PubMed 6263305

Publications 1980

Wist E (1980)
Effects of araC and aphidicolin on DNA chain elongation rate in HeLa S3 cells
Experientia, 36 (4), 405-6
DOI 10.1007/BF01975113, PubMed 6769693

Publications 1979

Wist E (1979)
The role of DNA polymerases alpha, beta and gamma in nuclear DNA synthesis
Biochim Biophys Acta, 562 (1), 62-9
DOI 10.1016/0005-2787(79)90126-6, PubMed 435500

Wist E (1979)
Partial purification of deoxyuridine triphosphate nucleotidohydrolase and its effect on DNA synthesis in isolated HeLa cell nuclei
Biochim Biophys Acta, 565 (1), 98-106
DOI 10.1016/0005-2787(79)90085-6, PubMed 508767

Wist E (1979)
Studies on DNA replication in HeLa cells
Institute of Medical Biology, University of Tromsø, Tromsø, 1 b. (fl. pag.)
BIBSYS 812114493

Wist E, Prydz H (1979)
The effect of aphidicolin on DNA synthesis in isolated HeLa cell nuclei
Nucleic Acids Res, 6 (4), 1583-90
DOI 10.1093/nar/6.4.1583, PubMed 450707

Wist E, Prydz H (1979)
No stimulatory effect of added histones on DNA synthesis in isolated HeLa cell nuclei
Mol Biol Rep, 5 (3), 189-91
DOI 10.1007/BF00778422, PubMed 492163

Publications 1978

Wist E, Krokan H (1978)
Preservation by glycerol of DNA synthetic capacity of isolated HeLa S(3) cell nuclei during long term storage at low temperature
Exp Cell Res, 116 (2), 313-6
DOI 10.1016/0014-4827(78)90453-6, PubMed 710528

Wist E, Unhjem O, Krokan H (1978)
Accumulation of small fragments of DNA in isolated HeLa cell nuclei due to transient incorporation of dUMP
Biochim Biophys Acta, 520 (2), 253-70
DOI 10.1016/0005-2787(78)90225-3, PubMed 708736

Publications 1977

Krokan H, Wist E, Prydz H (1977)
Effect of cytosol on DNA synthesis in isolated HeLa cell nuclei
Biochem Biophys Res Commun, 75 (2), 414-9
DOI 10.1016/0006-291x(77)91058-0, PubMed 851447

Krokan H, Wist E, Prydz H (1977)
DNA replication intermediates in whole HeLa cells and isolated nuclei
Biochim Biophys Acta, 475 (4), 553-61
DOI 10.1016/0005-2787(77)90316-1, PubMed 851539

Publications 1976

Wist E, Krokan H, Prydz H (1976)
Effect of 1-beta-D-arabinofuranosylcytosine triphosphate on DNA synthesis in isolated HeLa cell nuclei
Biochemistry, 15 (16), 3647-52
DOI 10.1021/bi00661a036, PubMed 952882

Page visits: 8504